Apoptosis inducer 20
Apoptosis inducer 20 (12) causes G2/M cell cycle arrest and induction of apoptosis via caspase 3/7 activation, which occurred during M arrest. Apoptosis inducer 20 is a novel indolic benzenesulfonamide with anti-proliferative effect against a broad panel of cancer cell lines, which is proming for research of new anti-mitotic agents.
For research use only. We do not sell to patients.
- Formula: C20H21N3O5S
- Molecular Weight:415.46
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A-375 | IC50 |
22.1 nM
Compound: 12
|
Antiproliferative activity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human A-375 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| BT-474 | IC50 |
68.3 nM
Compound: 12
|
Antiproliferative activity against human BT-474 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human BT-474 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| CAKI-1 | IC50 |
56.2 nM
Compound: 12
|
Antiproliferative activity against human CAKI-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human CAKI-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| HEK293 | IC50 |
23.4 nM
Compound: 12
|
Antiproliferative activity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human HEK293 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| HeLa | IC50 |
1.7 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
|
[PMID: 38959729] |
| HeLa | IC50 |
11 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| HeLa | IC50 |
16.3 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in presence of verapamil by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in presence of verapamil by MTT assay
|
[PMID: 38959729] |
| HeLa | IC50 |
22.3 nM
Compound: 12
|
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in absence of verapamil by MTT assay
Antiproliferative activity against human HeLa cells assessed as inhibition of cell growth incubated for 72 hrs in absence of verapamil by MTT assay
|
[PMID: 38959729] |
| HT-1080 | IC50 |
9.9 nM
Compound: 12
|
Antiproliferative activity against human HT-1080 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human HT-1080 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| MCF7 | IC50 |
13.7 nM
Compound: 12
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| MDA-MB-468 | IC50 |
13 nM
Compound: 12
|
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human MDA-MB-468 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| MES-SA | IC50 |
8.9 nM
Compound: 12
|
Antiproliferative activity against human MES-SA cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human MES-SA cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
| TERT-RPE1 | IC50 |
80.4 nM
Compound: 12
|
Antiproliferative activity against human RPE-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
Antiproliferative activity against human RPE-1 cells assessed as reduction in cell viability incubated for 72 hrs by CelltiterGlo luminescent assay
|
[PMID: 38959729] |
Apoptosis inducer 20 inhibits cell growth activity in different cancer cell lines. The melanoma cell-line MelMet5 is the most sensitive cell-line, followed by HeLa[1].
Apoptosis inducer 20 (100 nM, 24 h) causes G2/M cell cycle arrest and induction of apoptosis via caspase 3/7 activation in MES-SA cells[1].
Antiproliferative IC50 values of active sulfonamides on HeLa, MCF7, BT-474, MDA-MB468, MES-SA, HT-1080, MelMet5, A375, WM-1366, and Caki1 cancer cell lines[1]
| HeLa | MCF7 | BT-474 | MDA-MB468 | MES-SA | HT-1080 | MelMet5 | A375 | WM-1366 | Caki1 | |
| 12 | 11.0 | 13.7 | 68.3 | 13.0 | 8.9 | 9.9 | 8.9 | 22.1 | 52.8 | 56.2 |